Maypro named US distributor for AmealPeptide blood pressure ingredient

Related tags Blood pressure

Maypro named US distributor for AmealPeptide blood pressure ingredient
New York-based Maypro Industries has been named the US distributor of AmealPeptide, a patented clinically proven ingredient for healthy blood pressure from Calpis, Co., Ltd.

The ingredient has previously been available in the US and is currently being used in various supplement brands, a spokesperson for Maypro told NutraIngredients-USA, and Maypro will be selling to existing customers as well as new customers for this ingredient.

The ingredient is derived from enzymatically hydrolyzed casein and it acts as an ACE inhibitor. ACE inhibitors work by inhibiting the conversion of angiotensin I to the potent vasoconstrictor, angiotensin II, thereby improving blood flow and blood pressure. The ingredient’s efficacy is backed by 14 double-blind, placebo-controlled studies, said the company.

The spokesperson said that the structure-function claim used for the ingredient is:  ‘Helps to maintain a healthy blood pressure level that is already within the normal range’.

“Through Maypro’s distribution network, we hope more people will get a chance to take AmealPeptide so that we contribute to the improvement of everyone’s quality of life”​ said Shunsuke Fuji, senior officer, Calpis.

“It is an honor for us to represent one of Japan’s leading beverage companies and to offer a product supported by such an extensive body of clinical research,”​ said Steve Yamada, Maypro’s CEO.

Related news

Show more

Related products

show more

ioWhey™ for Enhanced Protein Absorption

ioWhey™ for Enhanced Protein Absorption

Content provided by Ingredient Optimized | 20-Sep-2023 | Product Brochure

ioWhey® uses a proprietary patented process to optimized whey protein isolate for superior bioavailability, greater absorption, and maximized performance....

Related suppliers

Follow us


View more